PUBLICATIONS · 18378568
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 May 20
- First author
- Kelly K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2008 May 20;26(15):2428-30. doi: 10.1200/JCO.2008.16.0374.
- note
- Source null
- related pmid
- 18378565
- relationship
- Comment in
- citation
- J Clin Oncol. 2008 Oct 10;26(29):4849-50; author reply 4850-1. doi: 10.1200/JCO.2008.18.7625.
- note
- Source null
- related pmid
- 18779595
- relationship
- Comment in
- citation
- J Clin Oncol. 2008 Oct 10;26(29):4848-9; author reply 4850-1. doi: 10.1200/JCO.2008.18.4218.
- note
- Source null
- related pmid
- 18779597
- relationship
- Comment in
Authors and identifiers
- name
- Kelly K
- type
- Author
- name
- Chansky K
- type
- Author
- name
- Gaspar LE
- type
- Author
- name
- Albain KS
- type
- Author
- name
- Jett J
- type
- Author
- name
- Ung YC
- type
- Author
- name
- Lau DH
- type
- Author
- name
- Crowley JJ
- type
- Author
- name
- Gandara DR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kelly K
- type
- Author
- name
- Chansky K
- type
- Author
- name
- Gaspar LE
- type
- Author
- name
- Albain KS
- type
- Author
- name
- Jett J
- type
- Author
- name
- Ung YC
- type
- Author
- name
- Lau DH
- type
- Author
- name
- Crowley JJ
- type
- Author
- name
- Gandara DR
- type
- Author
- bibliography ids
- nci-bib-94028f92e4540c2c104132a8
- book metadata
- content sha256
- 3fcbca2e805495a592639098112d33c36c95d5bc1e71b8237eea1df9c87b7633
- document type
- citation
- dois
- 10.1200/JCO.2007.14.4824
- electronic publication date
- display
- 2008 Mar 31
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18378568
- immutable id
- pubmed:18378568@3fcbca2e805495a592639098112d33c36c95d5bc1e71b8237eea1df9c87b7633
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 15
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2450-6
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2008 May 20;26(15):2428-30. doi: 10.1200/JCO.2008.16.0374.
- note
- Source null
- related pmid
- 18378565
- relationship
- Comment in
- citation
- J Clin Oncol. 2008 Oct 10;26(29):4849-50; author reply 4850-1. doi: 10.1200/JCO.2008.18.7625.
- note
- Source null
- related pmid
- 18779595
- relationship
- Comment in
- citation
- J Clin Oncol. 2008 Oct 10;26(29):4848-9; author reply 4850-1. doi: 10.1200/JCO.2008.18.4218.
- note
- Source null
- related pmid
- 18779597
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 18378568
- provenance
- batch id
- e663b4be92ee60a9b059
- provider
- NCBI PubMed ESummary
- record sha256
- 7053ccc85a9e1a526cd608b3395e78197fbe17bfdce9827c2c00a03c1611286f
- response sha256
- 514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
- retrieved at
- 2026-09-09T23:46:19.265979+00:00
- publication date
- display
- 2008 May 20
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.
Preserved source evidence · Not medical advice
Triangle